This article provides key insights and suggested best practices for managed care to improve patient care in MPS disorders, which may also be relevant to other rare and ultra-rare conditions.
AMCP Comments on CMS Medicare Program; International Pricing Index Model for Medicare Part B Drugs
The Academy of Managed Care Pharmacy (AMCP) appreciates the opportunity to provide comments in response to Centers for Medicare & Medicaid Services’ (CMS) Advanced Notice of Proposed Rulemaking (ANPRM) on the Medicare Program; International Pricing Index Model for Medicare Part B Drugs; [CMS5528-ANPRM]. AMCP is the nation’s leading professional association dedicated to increasing patient access to affordable medicines, improving health outcomes and ensuring the wise use of health care dollars. Through evidence- and value-based strategies and practices, the Academy’s 8,000 pharmacists, physicians, nurses and other practitioners manage medication therapies for the 270 million Americans served by health plans, pharmacy benefit management firms, emerging care models and government.
Related
As part of a multi-year RWE initiative, AMCP Research Institute partnered with IQVIA, payers, pharmaceutical companies, and others to design payer-focused RWE standards that were published in JMCP in September, 2025.
AMCP’s guidance translates CMS’s expectations for patient centered, evidence informed formulary decisions into practical steps payers can act on today without adding unnecessary burden to P&T workflows.
Featured News & Resources
See Full Calendar
Other Events
AMCP Ohio-Kentucky Day of Education 2026
Other Events
Mountain West Pharmacy Summit 2026
Other Events
Midwest 2026 Chicago Day of Education
Upcoming Events
AMCP offers a wide variety of educational opportunities, from events and webinars to online training.
